search
Back to results

Study Looking at the Effect of Silverlon on Post Operative Wound Infections

Primary Purpose

Infections, Surgery

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Silverlon
Standard of Care Dressing
Sponsored by
Jorge Marcet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Infections focused on measuring All patients undergoing a colorectal resection, surgical site infections

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. All patients undergoing elective colorectal surgery by a trained colorectal surgeon with an abdominal skin incision of at least 3 cm
  2. Patients that are willing and able to comply with the requirements of the protocol including follow-up requirements
  3. Patients willing and able to sign a study specific informed consent

Exclusion Criteria:

  1. Patients that fail to meet the skin incision size criteria
  2. Patients with a known allergy to silver
  3. Patients less than 18 years of age
  4. Any contraindication to undergoing a surgical procedure under general anesthesia
  5. Patients with preoperative evidence of a current abdominal wall infection/surgical site infection from a previous laparotomy/laparoscopy
  6. Patients that have received antibiotic therapy within the week prior to surgery
  7. Patients with preoperative evaluation suggestive of an intra-abdominal process that would preclude full closure of the skin
  8. Patients with a previously placed anterior abdominal wall mesh that is not planned to be completely removed during the planned procedure
  9. Women who are pregnant or breast feeding or are considering becoming pregnant during the follow-up period
  10. Mental incompetence as determined by the Investigator which would affect participation in the study
  11. Concurrently participating in any other investigational study

Sites / Locations

  • Tampa General Hospital and University of South Florida Medical Clinics

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Silverlon Dressing

Standard of Care Dressing

Arm Description

The Silverlon(Cura Surgical, Geneva, IL) dressing is applied to the surgical wound postoperatively. This dressing is coated with silver nylon.

The standard plain gauze is used to dress the wound postoperatively

Outcomes

Primary Outcome Measures

Surgical Site Infection
We will monitor the incision from the day of surgery to post operative day 30 to determine if the incision needs antibiotics.

Secondary Outcome Measures

Full Information

First Posted
March 24, 2010
Last Updated
June 11, 2013
Sponsor
Jorge Marcet
search

1. Study Identification

Unique Protocol Identification Number
NCT01143883
Brief Title
Study Looking at the Effect of Silverlon on Post Operative Wound Infections
Official Title
A Randomized Controlled Clinical Trial Evaluating the Efficacy of Silverlon® in Preventing Surgical Site Infection Following Colorectal Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
June 2013
Overall Recruitment Status
Completed
Study Start Date
June 2009 (undefined)
Primary Completion Date
September 2010 (Actual)
Study Completion Date
November 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Jorge Marcet

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This clinical study is a prospective, randomized, controlled trial of patients undergoing elective colorectal surgical procedures that receive an abdominal skin incision of at least 6 cm. Treatment with Silverlon® will be compared to standard postoperative dressings of 4x4 Gauze and paper tape. Patients will be randomized with a 1:1 treatment allocation ratio to receive either 1) Silverlon® or 2) standard postsurgical dressing. Neither the Investigators nor the participants will be blinded to the treatment modality after randomization. Silver has long been known to have antimicrobial properties. It interacts with structural proteins and DNA, inhibiting bacterial replication and causing fatal structural changes within the cell wall. It has broad antimicrobial activities and unlike antibiotics, it is rarely associated with microbial resistance. Silverlon® is a silver-nylon dressing specifically designed for surgical wounds to prevent the development of surgical site infections. It is an easy to use product with no known microbial resistance or adverse effects. The efficacy of Silverlon® in preventing surgical site infections has been shown in several retrospective studies but as of yet has not been tested in a prospective fashion. The objective of this study is to perform a prospective, randomized, clinical trial directly comparing the incidence of surgical site infections in patients treated with Silverlon® to standard postoperative dressing following elective colorectal surgery

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infections, Surgery
Keywords
All patients undergoing a colorectal resection, surgical site infections

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
110 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Silverlon Dressing
Arm Type
Experimental
Arm Description
The Silverlon(Cura Surgical, Geneva, IL) dressing is applied to the surgical wound postoperatively. This dressing is coated with silver nylon.
Arm Title
Standard of Care Dressing
Arm Type
Active Comparator
Arm Description
The standard plain gauze is used to dress the wound postoperatively
Intervention Type
Other
Intervention Name(s)
Silverlon
Intervention Description
Silverlon dressings are gauze impregnated with silver ions
Intervention Type
Other
Intervention Name(s)
Standard of Care Dressing
Intervention Description
Standard dry gauze dressing
Primary Outcome Measure Information:
Title
Surgical Site Infection
Description
We will monitor the incision from the day of surgery to post operative day 30 to determine if the incision needs antibiotics.
Time Frame
Day of surgery up to 30 days post operatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All patients undergoing elective colorectal surgery by a trained colorectal surgeon with an abdominal skin incision of at least 3 cm Patients that are willing and able to comply with the requirements of the protocol including follow-up requirements Patients willing and able to sign a study specific informed consent Exclusion Criteria: Patients that fail to meet the skin incision size criteria Patients with a known allergy to silver Patients less than 18 years of age Any contraindication to undergoing a surgical procedure under general anesthesia Patients with preoperative evidence of a current abdominal wall infection/surgical site infection from a previous laparotomy/laparoscopy Patients that have received antibiotic therapy within the week prior to surgery Patients with preoperative evaluation suggestive of an intra-abdominal process that would preclude full closure of the skin Patients with a previously placed anterior abdominal wall mesh that is not planned to be completely removed during the planned procedure Women who are pregnant or breast feeding or are considering becoming pregnant during the follow-up period Mental incompetence as determined by the Investigator which would affect participation in the study Concurrently participating in any other investigational study
Facility Information:
Facility Name
Tampa General Hospital and University of South Florida Medical Clinics
City
Tampa
State/Province
Florida
ZIP/Postal Code
33606
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
21730792
Citation
Krieger BR, Davis DM, Sanchez JE, Mateka JJ, Nfonsam VN, Frattini JC, Marcet JE. The use of silver nylon in preventing surgical site infections following colon and rectal surgery. Dis Colon Rectum. 2011 Aug;54(8):1014-9. doi: 10.1097/DCR.0b013e31821c495d.
Results Reference
derived

Learn more about this trial

Study Looking at the Effect of Silverlon on Post Operative Wound Infections

We'll reach out to this number within 24 hrs